Ligand Pharmaceuticals seeks to discover disease-curing molecules. The drug development company works with gene transcription technology to address assorted illnesses. Its research and development projects include treatments for thrombocytopenia (low platelet count), osteoporosis, Alzheimer's disease, hepatitis C, cancers, cardiovascular ailments, arthritis, asthma, and diabetes. Ligand Pharmaceuticals conducts many of its programs through partnerships with other drugmakers. The company is focused on expanding its development pipeline through additional partnerships, as well as via acquisitions.